Strategic Blueprint, LLC Arrowhead Pharmaceuticals, Inc. Transaction History
Strategic Blueprint, LLC
- $1.38 Billion
- Q2 2024
Shares
2 transactions
Others Institutions Holding ARWR
# of Institutions
295Shares Held
92.3MCall Options Held
1.33MPut Options Held
549K-
Black Rock Inc. New York, NY15.7MShares$296 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.2MShares$230 Million0.01% of portfolio
-
Avoro Capital Advisors LLC New York, NY8.89MShares$168 Million3.15% of portfolio
-
State Street Corp Boston, MA5.84MShares$110 Million0.01% of portfolio
-
Slate Path Capital LP New York, NY4.14MShares$78 Million2.11% of portfolio
About ARROWHEAD PHARMACEUTICALS, INC.
- Ticker ARWR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 105,849,000
- Market Cap $2B
- Description
- Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...